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 ABSTRACT  
 
Phytoestrogens have some important biological effects and could be employed as medicinal resources, 
for example as cancer chemopreventive agents. Phytoestrogen is defined as a phytochemical that has 
estrogenic or anti estrogenic effects. However, there is no database providing comprehensive list of 
phytoestrogen structures. In computer-aided drug discovery, the database is required to perform virtual 
screening for retrospective validation and structure-based drug design. The research presented in this article 
attempted to collect a comprehensive list of phytoestrogen structures. Subsequently, the structures were 
prepared in their three dimensional structures using SPORES1.3 for molecular docking simulations using 
PLANTS1.2. The ready-to-dock structures were then stored online as phytoestrogens.zip and could be 
downloaded from http://molmod.org/phytoestrogens.zip. This database contains 30 ready-to-dock unique 
phytoestrogens with total of 53 different configurations.  
Keywords: Phytoestrogen, database, drug discovery, molecular docking 
 
ABSTRAK 
 
Fitoestrogen merupakan senyawa memiliki aktivitas biologis penting bahkan seringkali berpotensi 
sebagai agen kemoprevensi kanker. Fitoestrogen didefinisikan sebagai senyawa-senyawa alami dari 
tanaman yang memiliki efek estrogenik atau anti estrogenik. Meskipun demikian, sejauh ini belum ditemui 
basis data yang menyediakan struktur-struktur fitoestrogen secara komprehensif. Hal ini dapat 
menghambat penemuan obat berbantukan komputer ketika ketersediaan basis data sangat penting untuk 
melakukan penapisan virtual guna validasi retrospektif atau perancangan obat berbasis struktur. Penelitian 
yang disampaikan di artikel ini mencoba mengumpulkan struktur-struktur fitoestrogen secara komprehensif 
dan melakukan preparasi untuk membuat struktur-struktur tersebut dalam bentuk tiga dimensi dengan 
aplikasi SPORES1.3 dan siap menjadi berkas masukan untuk simulasi penambatan molekuler PLANTS1.2. 
Struktur-struktur siap ditambatkan tersebut kemudian disimpan dalam jaringan sebagai  phytoestrogens.zip 
dan bisa diunduh di http://molmod.org/phytoestrogens.zip. Database ini memuat 30 struktur fitoestrogen 
dengan total 53 konfigurasi yang berbeda yang siap menjadi input simulasi penambatan molekuler. 
Kata kunci: Fitoestrogen, basis data, penemuan obat, penambatan molekuler 
 
INTRODUCTION 
Drugs discoveries have owed phyto-
chemicals since they have become main resources 
for inspirations or even lead compounds in                   
the early stages of the discovery and development 
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(Brusotti et al., 2014; Efferth and Koch, 2011). 
Currently, drug discovery targeting breast cancer 
has become of timely and considerable interest 
since there is no recent breakthrough in the 
therapy (Cardoso and Senkus, 2015). Screening 
campaigns on phytochemicals to discover breast 
cancer chemopreventive agents have been 
performed, since it is believed to be able to serve 
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as starting points to discover novel breast cancer 
drugs (Balunas et al., 2008; Helferich et al., 2008; 
Istyastono, 2015; Setiawati et al., 2014a; Shibata et 
al., 2011; Vidhya and Devaraj, 2011). In the 
molecular level, one of the main targets to 
discover novel breast cancer chemopreventive 
agents is estrogen receptor α (ERα) (Ali and 
Coombes, 2000; Anita et al., 2015, 2012; 
Istyastono, 2015; Radifar et al., 2013; Setiawati et 
al., 2014a; Shiau et al., 1998).  
Phytochemicals showed that estrogenic or 
anti estrogenic effects are, by definition, classed as 
phytoestrogens (Dixon, 2004; Helferich et al., 
2008). As ligands for estrogen receptors, these 
phytochemicals could show the estrogenic or anti 
estrogenic effects (Helferich et al., 2008). Certain 
isoflavonoids, flavonoids, stilbenes, and lignans 
were identified as phytoestrogens (Dixon, 2004). 
Notably, the best studied phytoestrogen is the soy 
isoflavone genistein (Dixon, 2004; Helferich et al., 
2008; Varinska et al., 2015). The interests on 
phytoestrogen have emerged not only related to 
their potency as breast cancer chemopreventive 
agents (Balunas et al., 2008; Helferich et al., 2008; 
Setiawati et al., 2014a; Setiawati et al., 2014b), but 
also their roles in osteoporosis, cognitive function, 
cardiovascular disease, immunity and 
inflammation, and reproduction (Dixon, 2004). 
However, although many phytochemicals were 
identified as phytoestrogens (Dixon, 2004; 
Helferich et al., 2008), the comprehensive list of 
phytoestrogen is not available yet. The lack of this 
list hinders the attempts to thoroughly study how 
they bind to the receptors especially to ERα 
(Istyastono, 2015; Pathania et al., 2015; Setiawati 
et al., 2014a), which in turn could efficiently assist 
the discovery of novel ligands for the receptors 
(Istyastono et al., 2015a; Istyastono et al., 2015b; 
Kufareva et al., 2014; Pathania et al., 2015). 
This article presents the attempts to collect 
the structures of known phytoestrogens. The 
collected structures were virtually prepared using 
previously published ligand preparation 
procedures (Istyastono and Setyaningsih, 2015) to 
be ready for molecular docking simulations. This 
involved the generations of their three-
dimensional (3D) structures (Istyastono and 
Setyaningsih, 2015; Setiawati et al., 2014a). The 
structures in their ready-to-dock formats were 
subsequently stored online as phytoestrogens.zip 
and could be obtained from 
http://molmod.org/phytoestrogens.zip for further 
usages. Additionally, this article presents also the 
molecular docking studies of genistein as the best 
studied phytoestrogen in the ERα binding pocket. 
The atomic interactions of the resulted pose to the 
ERα binding pocket were then compared to the 
interactions of the pose of the co-crystal ligand 4-
hydroxytamoxifen (4-OHT). 
 
METHODOLOGY 
Materials and Instrumentation 
The phytochemicals mentioned in Dixon 
(2004) were used as the starting points. The ZINC 
and ChEMBL databases were the main references 
to obtain the phytoestrogen structure (Bento et al., 
2014; Irwin et al., 2012). The crystal structure of 
ERα obtained from the protein data bank (PDB) 
with PDB id of 3ERT (Shiau et al., 1998) was used 
as the reference structure for molecular docking 
simulations. Files plants.config, protein.mol2, 
and water.mol2 to perform the simulations were 
obtained from Anita et al. (2012).  
Computational medicinal chemistry 
applications employed in this research were 
SPORES version 1.3 or SPORES1.3 (ten Brink and 
Exner, 2009), PLANTS version 1.2 or PLANTS1.2 
(Korb et al., 2009; Korb et al., 2007), Open Babel 
2.2.3 (O’Boyle et al., 2011), and PyMOL 1.2r1 (Lill 
and Danielson, 2011). All computations were 
performed in a Virtual Private Server (VPS) with 
internet protocol (IP) address of 103.247.10.66. 
The server has Ubuntu 12.04.3 LTS as the 
operating system, Intel(R) Xeon(R) E5630  Quad 
Core @ 2.53GHz as the processor and 1 GB of 
RAM. 
 
Computational Details 
The SMILES format of all compounds with 
estrogenic or anti estrogenic activity mentioned in 
Dixon (2004) were obtained from either ZINC 
database (Irwin et al., 2012) or ChEMBL database 
(Bento et al., 2014). Each compound was then 
subjected to Open Babel 2.2.3 conversion software 
to be converted in its three dimensional (3D) 
format as a mol2 file. The reprot module in 
SPORES1.3 was subsequently employed to 
properly check and assign the mol2 file into a 
proper mol2 file with standard protonated state 
(ten Brink and Exner, 2009). This mol2 file was 
ready to be docked by using PLANTS1.2 docking 
software. The ready-to-dock mol2 files were 
compressed to a zip file and the zip file was 
subsequently uploaded to http://molmod.org/. 
The file was subsequently downloaded to 
the VPS and unzipped. The mol2 structures were 
then docked into ERα binding pocket employing 
PLANTS1.2 molecular docking software by 
following the previously published procedures by 
Anita et al. (2012) to examine if the structures 
were the ready-to-dock ones. The docking results 
were compressed to a zip file and the zip file was 
also uploaded to http://molmod.org/.  
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Visual inspections of the best pose of genistein 
resulted from the molecular docking simulations 
using PyMOL (Lill and Danielson, 2011) was then 
performed to analyze the plausible molecular 
determinants of ERα-phytoestrogen binding.  
 
RESULTS AND DISCUSSION 
According to Dixon (2004), phytoestrogens 
were classified into isoflavonoid (Table I), 
flavonoid (Table II) and lignan (Table III) 
phytoestrogens. Beside those three main classes, 
there were other phytoestrogens, including 
chalcone and anthraquinone phytoestrogens 
(Table IV). Notably, there are still some other 
phytochemicals which have estrogenic or anti 
estrogenic effects but not listed in those tables 
(Tables I-IV), for example eugenol, alizarin, α-
mangostin (Matsuda et al., 2001; Shibata et al., 
2011). Nevertheless, to construct a comprehensive 
phytoestrogen structure database requires 
starting points (Pathania et al., 2015) and the 
review on phytoestrogens by Dixon (2004) could 
serve as the starting points since it has covered 
most phytoestrogen classes and discussed the 
potent ones (Dixon, 2004; Helferich et al., 2008; 
Mysinger et al., 2012).  
In total, there were 30 unique 
phytoestrogens presented in Tables I-IV. Since one 
compound could have more than one 3D 
configuration, there were 53 structural 
configurations indicated by the SMILES formats in 
Tables I-IV. ChEMBL database (Bento et al., 2014) 
was subsequently inspected to append the 
information with the biological activities of the 
listed phytoestrogens at ERα. The results are 
presented in Table V. Only 9 phytoestrogens with 
biological activities at ERα are listed (Table V and 
Figure 1).  
Table I. Name and structures (in SMILES format) of isoflavonoid phytoestrogens mentioned by Dixon 
(2004). 
 
ZINC No.a) Structure in SMILES formata) Nameb) 
18847037 COc1ccc(cc1)c2coc3cc(cc(c3c2=O)O)O biochanin A 
1219 c1cc2c(cc1O)oc3c2c(=O)oc4c3ccc(c4)O coumestrol 
18847034 c1cc(ccc1c2coc3cc(ccc3c2=O)O)O daidzein 
4098610 c1cc(ccc1c2coc3cc(ccc3c2=O)O[C@H]4[C@@H]([C@H]([C@@H]([C@
H](O4)CO)O)O)O)O 
daidzin c) 
388660 c1cc(ccc1[C@H]2Cc3ccc(cc3OC2)O)O equol 
388661 c1cc(ccc1[C@@H]2Cc3ccc(cc3OC2)O)O equol 
18847036 COc1ccc(cc1)c2coc3cc(ccc3c2=O)O formononetin 
18825330 c1cc(ccc1c2coc3cc(cc(c3c2=O)O)O)O genistein 
4097913 c1cc(ccc1c2coc3cc(cc(c3c2=O)O)O[C@H]4[C@@H]([C@H]([C@@H]([
C@H](O4)CO)O)O)O)O 
genistinc) 
33831433 CC1(C=Cc2c(ccc(c2O)C3=Cc4ccc(cc4OC3)O)O1)C glabrene 
5963549 CC1(C=Cc2c(ccc(c2O1)C3=Cc4ccc(cc4OC3)O)O)C glabrene 
4098719 CC1(C=Cc2c(ccc3c2OC[C@H](C3)c4ccc(cc4O)O)O1)C glabridin 
899797 CC1(C=Cc2c(ccc3c2OC[C@@H](C3)c4ccc(cc4O)O)O1)C glabridin 
5999205 COc1cc2c(cc1O)occ(c2=O)c3ccc(cc3)O glycitein 
3872928 CC(C)Oc1ccc2c(=O)cc(oc2c1)c3ccccc3 ipriflavone 
4016 CC(C)Oc1ccc2c(c1)occ(c2=O)c3ccccc3 ipriflavone 
14727569 CC(=CCc1c(ccc(c1O)[C@@H]2Cc3c(cc(c(c3OC)CC=C(C)C)O)OC2)O)C licoricidin 
5854565 CC(=CCc1c(ccc(c1O)[C@H]2Cc3c(cc(c(c3OC)CC=C(C)C)O)OC2)O)C licoricidin 
59729510 CC(C)/C=C/c1c(ccc(c1O)[C@@H]2Cc3c(cc(c(c3O)CC=C(C)C)OC)OC2)
O 
licoricidin 
59729511 CC(C)/C=C/c1c(ccc(c1O)[C@H]2Cc3c(cc(c(c3O)CC=C(C)C)OC)OC2)O licoricidin 
985403 c1cc(ccc1[C@@H]2CC(=O)c3ccc(cc3O2)O)O liquiritigenin 
156701 c1cc(ccc1[C@@H]2CC(=O)c3c(cc(cc3O2)O)O)O naringenin 
1785 c1cc(ccc1[C@H]2CC(=O)c3c(cc(cc3O2)O)O)O naringenin 
4098745 c1cc(ccc1c2coc3c(c2=O)ccc(c3[C@H]4[C@@H]([C@H]([C@@H]([C@
H](O4)CO)O)O)O)O)O 
puerarin c) 
 
a)One compound with more than one possible 3D configuration could have more than one structure in SMILES format 
(Bento et al., 2014; Irwin et al., 2012); b)As mentioned by Dixon (2004); c)For glycosides, only one configuration is 
included in the list since they have more than 5 different 3D configurations.  
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Table II. Name and structures (in SMILES format) of flavonoid phytoestrogens mentioned by Dixon 
(2004). 
 
ZINC No.a) Structure in SMILES formata) Nameb) 
3873159 CC(=CCc1c(c(c2c(c1O)C(=O)C[C@H](O2)c3ccc(cc3)O)CC=C(
C)C)O)C 
6,8-diprenylnaringenin 
4098363 CC(=CCc1c(cc2c(c1O)C(=O)C[C@H](O2)c3ccc(cc3)O)O)C 6-prenylnaringenin 
5854068 CC(=CCC/C(=C/Cc1c(cc(c2c1O[C@@H](CC2=O)c3ccc(cc3)O)
O)O)/C)C 
8-geranylnaringenin 
39451 CC(=CCc1c(cc(c2c1O[C@H](CC2=O)c3ccc(cc3)O)O)O)C 8-prenylnaringenin 
39452 CC(=CCc1c(cc(c2c1O[C@@H](CC2=O)c3ccc(cc3)O)O)O)C 8-prenylnaringenin 
12353732 c1cc(ccc1/C=C\c2cc(cc(c2)O)O)O resveratrolc) 
6787 c1cc(ccc1/C=C/c2cc(cc(c2)O)O)O resveratrolc) 
2008845 CC(=CC[C@@H](Cc1c(cc(c2c1O[C@H](CC2=O)c3ccc(cc3O)O
)O)O)C(=C)C)C 
sophoraflavanone_G 
2008847 CC(=CC[C@H](Cc1c(cc(c2c1O[C@H](CC2=O)c3ccc(cc3O)O)O
)O)C(=C)C)C 
sophoraflavanone_G 
2008848 CC(=CC[C@@H](Cc1c(cc(c2c1O[C@@H](CC2=O)c3ccc(cc3O)
O)O)O)C(=C)C)C 
sophoraflavanone_G 
2008850 CC(=CC[C@H](Cc1c(cc(c2c1O[C@@H](CC2=O)c3ccc(cc3O)O
)O)O)C(=C)C)C 
sophoraflavanone_G 
 
a)One compound with more than one possible 3D configuration could have more than one structure in 
SMILES format (Bento et al., 2014; Irwin et al., 2012); b)As mentioned by Dixon (2004); c)Resveratrol was 
classified here since the biosynthesis was related to flavonoids (Dixon, 2004). 
 
 
Table III. Name and structures (in SMILES format) of lignan phytoestrogens mentioned by Dixon (2004). 
 
ZINC No.a) Structure in SMILES formata) Nameb) 
1360 c1cc(cc(c1)O)C[C@@H]2COC(=O)[C@H]2Cc3cccc(c3)O enterolactone 
388657 c1cc(cc(c1)O)C[C@H]2COC(=O)[C@H]2Cc3cccc(c3)O enterolactone 
388658 c1cc(cc(c1)O)C[C@H]2COC(=O)[C@@H]2Cc3cccc(c3)O enterolactone 
388659 c1cc(cc(c1)O)C[C@@H]2COC(=O)[C@@H]2Cc3cccc(c3)O enterolactone 
4098820 COc1cc(ccc1O)C[C@H]2CO[C@@H]([C@H]2CO)c3ccc(c(c3)OC)O lariciresinol 
1595956 COc1cc(ccc1O)C[C@H]2COC(=O)[C@H]2Cc3ccc(c(c3)OC)O matairesinol 
1595957 COc1cc(ccc1O)C[C@H]2COC(=O)[C@@H]2Cc3ccc(c(c3)OC)O matairesinol 
1595958 COc1cc(ccc1O)C[C@@H]2COC(=O)[C@@H]2Cc3ccc(c(c3)OC)O matairesinol 
900187 COc1cc(ccc1O)C[C@@H]2COC(=O)[C@H]2Cc3ccc(c(c3)OC)O matairesinol 
4098921 COc1cc(ccc1O)[C@@H]2[C@H]3CO[C@@H]([C@H]3CO2)c4ccc(c(
c4)OC)O 
pinoresinol 
2020114 COc1cc(ccc1O)C[C@@H](CO)[C@@H](Cc2ccc(c(c2)OC)O)CO secoisolariciresinol 
14435411 COc1cc(cc(c1O)OC)[C@@H]2[C@@H]3CO[C@H]([C@H]3CO2)c4c
c(c(c(c4)OC)O)OC 
syringaresinol 
18283077 COc1cc(cc(c1O)OC)[C@@H]2[C@@H]3CO[C@@H]([C@H]3CO2)c
4cc(c(c(c4)OC)O)OC 
syringaresinol 
5998957 COc1cc(cc(c1O)OC)[C@@H]2[C@@H]3CO[C@@H]([C@@H]3CO2
)c4cc(c(c(c4)OC)O)OC 
syringaresinol 
5998959 COc1cc(cc(c1O)OC)[C@@H]2[C@@H]3CO[C@H]([C@@H]3CO2)c
4cc(c(c(c4)OC)O)OC 
syringaresinol 
 
a)One compound with more than one possible 3D configuration could have more than one structure in 
SMILES format (Bento et al., 2014; Irwin et al., 2012); b)As mentioned by Dixon (2004). 
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Remarkably, all listed active phytoestrogens 
shared similar pharmacophore, i.e. they had 
hydroxyl phenolic and carbonyl moieties 
separated by 5 heavy atoms (Table V and Figure 
1). 
For the purpose of creating the database          
of the ready-to-dock phytoestrogens, an smi          
file named phytoestrogens.smi containing          
all listed structures in Tables I-IV was           
created.  The structure of the  file  is   as   follows:  
Table IV. Name and structures (in SMILES format) of other classes (chalcone and anthraquinone) 
phytoestrogens mentioned by Dixon (2004). 
 
ZINC No.a) Structure in SMILES formata) Nameb) 
3860201 c1cc2c(cc1O)C(=O)c3ccc(cc3C2=O)O 2,6-dihydroxyanthraquinone 
3824868 Cc1cc2c(c(c1)O)C(=O)c3c(cc(cc3O)O)C2=O emodin 
3869608 c1cc(ccc1/C=C/C(=O)c2ccc(cc2O)O)O isoliquiritigenin 
 
a)One compound with more than one possible 3D configuration could have more than one structure in SMILES format 
(Bento et al., 2014; Irwin et al., 2012); b)As mentioned by Dixon (2004). 
 
Table V. Biological activities (IC50) at ERα of some listed phytoestrogens (Bento et al., 2014). 
 
Name 
ChEMBLa) 
IC50 (nM)b) 
Compound Identity Assay Identity 
Coumestrol CHEMBL30707 CHEMBL827788 76  
Daidzein CHEMBL8145 CHEMBL1219560 450  
Genistein CHEMBL44 CHEMBL891640 395 
Ipriflavone CHEMBL165790 CHEMBL1909145 Not active 
Naringenin CHEMBL9352 CHEMBL909843 75,302 
8-prenylnaringenin CHEMBL460647 CHEMBL909843 57 
Resveratrol CHEMBL165 CHEMBL1909145 Not active 
2,6-Dihydroxyanthraquinone CHEMBL298398 CHEMBL679893 1100 
Emodin CHEMBL289277 CHEMBL679893 2700 
 
a)Ref: (Bento et al., 2014); b)If there were more than one biological activities listed in the database, the most recent 
one was selected. 
 
 
 
 
Figure 1. Stuctures (in two-dimensional format converted from the SMILES format) of some 
phytoestrogens (Table V). 
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[SMILES] molmodID_zincID_name. For example, 
biochanin A (Table I) was written in the first line 
of phytoestrogens.smi as follows: 
COc1ccc(cc1)c2coc3cc(cc(c3c2=O)O)O 
pe01_18847037_biochaninA. Following the 
procedures aforementioned resulted in a zip file 
with size of 70 kilobytes. This file has been 
uploaded and attached to http://molmod.org/ and 
could therefore be obtained from 
http://molmod.org/phytoestrogens.zip. In order 
to check the readiness of the uploaded ready-to-
dock mol2 file, further molecular docking 
simulations employing previously published 
procedure by Anita et al. (2012) were performed.  
The docking simulations ran without giving any 
error messages. This confirmed that the uploaded 
input files were the ready-to-dock structures. For 
further analysis by public, the docking results 
were zipped in a zip file with size of 12 megabytes 
and the zip file was uploaded to 
http://molmod.org/ and can be obtained from 
http://molmod.org/phytoestrogens.PLANTS.zip. 
The best studied phytoestrogen genistein 
(Dixon, 2004; Helferich et al., 2008; Varinska et al., 
 
 
Figure 2. Flowchart of the ligand preparation process suggested in this article with genistein as the 
representative. 
 
 
 
 
Figure 3. Binding poses genistein (A) and the co-crystal ligand 4-hydroxy tamoxifen (B) in the ERá 
binding pocket (Anita et al., 2012; Shiau et al., 1998). The ERá is presented in the cartoon mode with 
carbon atoms are in green, while the ligands are presented in the sticks mode with carbon atoms are in 
magenta. Only polar hydrogens (presented in white), residues (presented in sticks mode, carbon atoms 
are in green) with hydrogen bond interaction (presented in black dashes) and ionic interaction 
(presented in red dashes) to the ligand and a conserved water molecule (Anita et al., 2012) are presented 
for the sake of clarity. Nitrogen and oxygen atoms are presented in blue and red, respectively. These 
figures adopted the similar figures published by Setiawati et al. (2014) 
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2015) was selected as the representative for visual 
inspections. The process of transforming genistein 
from its SMILES format to the ready-to-dock 3D 
format is depicted in Figure 2. The best docking 
pose of genistein in the ERα binding pocket is 
presented in Figure 3. 
Based on Figures 2 and 3, it could be 
concluded that the resulted mol2 files were ready 
to be docked using PLANTS1.2. Moreover, by 
examining the binding poses of genistein and 4-
OHT in the ERα binding pocket (Figure 3), the 
important binding interactions could be identified: 
the hydrogen bond network between genistein, 
GLU353, ARG394, and the conserved water 
molecule (Anita et al., 2012; Shiau et al., 1998). 
This is in line with the identified pharmacophore 
by examining Figure 1. Notably, the aromatic 
moieties of genistein align very similarly to the 
aromatic moieties of 4-OHT when they bind to 
ERα. Thus GLU353, ARG394, and the aromatic 
residue around genistein in the ERα binding 
pocket are highly suggested as the molecular 
determinants of ERα-ligand binding. The most 
plausible aromatic residue as the molecular 
determinant in the ERα binding pocket is TRP383 
(Istyastono, 2015). 
 
CONCLUSION 
The database of ready-to-dock 3D 
structures of phytoestrogens resulted in this 
research could be employed further to study the 
atomic level of their estrogenic or anti estrogenic 
activities. Genistein as the representative 
phytoestrogen employed further in molecular 
docking simulations into ERα has unraveled some 
the molecular determinants in the ERα-ligand 
binding: GLU353, TRP383 and ARG394. 
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